Basilea Pharmaceutica (CHIX:BSLNZ) Short-Term Debt : CHF0.0 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Basilea Pharmaceutica Short-Term Debt?

Basilea Pharmaceutica's Short-Term Debt for the quarter that ended in Dec. 2024 was CHF0.0 Mil.

Basilea Pharmaceutica's quarterly Short-Term Debt declined from Dec. 2023 (CHF15.5 Mil) to Jun. 2024 (CHF0.0 Mil) but then stayed the same from Jun. 2024 (CHF0.0 Mil) to Dec. 2024 (CHF0.0 Mil).

Basilea Pharmaceutica's annual Short-Term Debt declined from Dec. 2022 (CHF37.5 Mil) to Dec. 2023 (CHF15.5 Mil) and declined from Dec. 2023 (CHF15.5 Mil) to Dec. 2024 (CHF0.0 Mil).

Basilea Pharmaceutica Short-Term Debt Historical Data

The historical data trend for Basilea Pharmaceutica's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Short-Term Debt Chart

Basilea Pharmaceutica Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

123.51

37.47

15.45

Basilea Pharmaceutica Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															37.47	37.92	15.45	-	-

Basilea Pharmaceutica Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Basilea Pharmaceutica Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (CHIX:BSLNz) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

BPMUF:USA 0QNA:UK BSLN:Switzerland

Address

Hegenheimermattweg 167b, Allschwil, CHE, 4123

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica Headlines

No Headlines